International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8006883
Original Article
A Study of Thyroid Dysfunction in Patients with Provisional Diagnosis of Abnormal Uterine Bleeding
 ,
Published
June 5, 2023
Abstract
Background: Abnormal uterine bleeding is an abnormal bleeding from the uterus in absence of organic disease of genital tract. AUB accounts for 10% of all gynaecology related complaints. Thyroid dysfunction by large number is associated with menstrual disorders. Objective: To study thyroid dysfunction in patients with a provisional diagnosis of AUB of all age groups and refer positive cases to physician for further evaluation. Methods: Clinically diagnosed cases of AUB were enrolled from gynaecology OPD of a tertiary hospital. All patients from puberty to premenopausal age groups presenting as menorrhagia, polymenorrhagia, oligomenorrhoea, polymenorrhoea and metrorrhagia were subjected to the thyroid function i.e. T3, T4, and TSH. All data was compiled and analysed. Results: A total of 101 patients were studied. 22.77% of these patients had thyroid dysfunction of which 13% of patients had hypothyroidism, 8% of patients had subclinical hypothyroidism and only 2% of patients had hyperthyroidism. The commonest bleeding abnormality in hypothyroid patients were polymenorrhoea and menorrhagia. All hyperthyroid cases were oligomenorrhoeic. Conclusion: Both hypothyroid and subclinical hypothyroid cases were the commonest thyroid dysfunction and menorrhagia was their commonest menstrual abnormality. So this study concludes that biochemical evaluation of thyroid functioning should be made in all provisionally diagnosed cases of AUB to detect thyroid dysfunction.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
2099 Views
362 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved